drugset / Trial / NCT00520936
A Study of Pemetrexed in Children With Recurrent Cancer
Non-randomizedSingle-groupOpen-labelTreatment
Summary
To determine the response rate of pemetrexed given every 21 days for the treatment of children with relapsed or refractory osteosarcoma, Ewing's sarcoma/peripheral primitive neuroectodermal tumors (PNET), rhabdomyosarcoma, neuroblastoma, ependymoma, medulloblastoma/supratentorial PNET or non-brain stem high-grade glioma.
Timeline
- Start
- 2007-09
- Primary completion
- 2010-02
- Completion
- 2010-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pemetrexed | Small molecule | 60 mg/kg | Intravenous |
| Subject | Pemetrexed | Small molecule | 1910 mg/m2 | Intravenous |